Content
UnitedHealth Group: High-Quality Dividend Stock
Article By:
Dividend Power
Read
Thursday, April 25, 2024 1:32 PM EDT
UNH stock has increased its dividend for 14 consecutive years. UNH’s most recent dividend increase was 13.9%, announced in June 2023. People should expect another increase in June 2024.
In this article: UNH
US Stock: Johnson & Johnson
Article By:
Andrew Stotz
Read
Thursday, April 25, 2024 6:45 AM EDT
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field.
In this article: JNJ
Humana Stock Drops Over 5% As Firm Pulls Guidance
Article By:
The Tokenist
Read
Wednesday, April 24, 2024 12:15 PM EDT
Humana withdrew its 2025 guidance due to Medicare Advantage uncertainties. The stock dropped over 5%.
In this article: HUM
Johnson & Johnson Stocks Elliott Wave Technical Analysis
Article By:
Peter Mathers
Read
Wednesday, April 24, 2024 6:36 AM EDT
Looking for support as we touched 0.618 Z vs. X. If we find resistance on Medium Level at 150 then we can expected further downside.
In this article: JNJ
US Stock: Pfizer
Article By:
Andrew Stotz
Read
Tuesday, April 23, 2024 7:00 AM EDT
Pfizer is engaged in the discovery, development, manufacture, marketing, sale, and distribution of biopharmaceutical products worldwide.
In this article: PFE
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
Article By:
The Tokenist
Read
Wednesday, April 17, 2024 9:30 AM EDT
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.
In this article: ABT
UnitedHealth Group Beats Q1 Expectations, Revenues Surge To $99.8 Billion
Article By:
The Tokenist
Read
Tuesday, April 16, 2024 7:25 AM EDT
UnitedHealth Group has reported strong first quarter 2024 results, with revenues reaching $99.8 billion.
In this article: UNH
Marijuana Stocks Followed The Leader Last Week Tumbling 12%, On Average
Article By:
Lorimer Wilson
Read
Sunday, April 14, 2024 6:20 PM EDT
The bad news from Tilray (its Q3 net loss increased by 128%} took a toll last week on the constituents of both the Canadian Cannabis LPs Index and the American Cannabis MSOs Index with all 12 declining by an average of 12%.
Viking Therapeutics: Strong Results In Obesity
Article By:
MoneyShow.com
Read
Saturday, April 13, 2024 5:17 PM EDT
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100 billion market for weight loss drugs.